The Future of Additive Manufacturing Seeks Talent for Growth

 

The bright future of additive manufacturing creates a tectonic shift in the manufacturing industry. This innovative process, which builds 3D objects layer-by-layer from a digital model, redefines how products are designed and produced and are poised to transform the very structure of industries.The stakes are high; in a recent announcement, Siemens confirmed plans to invest 2.2 billion euros into ramping up their global additive manufacturing capacities. As such, the critical question now is how companies can embrace the future of additive manufacturing as a crucial component and how they can foster the talent and skills needed to navigate this brave new world.

Additive manufacturing is the probing issue under scrutiny in the latest episode of DisruptED Advanced Manufacturing Edition, hosted by Ron J. Stefanski. In this second installment on the disruption in additive manufacturing, Steve Vosmik, the Head of Additive Manufacturing at Siemens, rejoins Stefanski to continue their conversation about the future of manufacturing and additive manufacturing’s role.

Their discussion includes the following highlights:

  • The impact of additive manufacturing on traditional manufacturing practices and the emerging trend of the innovation hub model
  • The crucial role that talent and skills play in the age of additive manufacturing and how educational institutions and industry can work together to cultivate the necessary expertise
  • The importance of passion, perseverance, and adaptability in the constantly evolving landscape of additive manufacturing

Steve Vosmik is a man of exceptional determination and creativity. His non-traditional path to additive manufacturing offers a unique perspective on the industry. Despite not having an engineering background, Steve has spearheaded Siemens’ efforts in additive manufacturing. His wealth of experience and keen insights into this disruptive technology make him a voice to heed in advanced manufacturing.

Join Stefanski and Vosmik as they delve into the potential of additive manufacturing, explore how it’s reshaping industries, and discuss the role that passionate, persistent, and tech-savvy individuals will play in this manufacturing revolution.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More